Chronic lymphocytic leukemia (CLL), breast, ovarian, liver, lung cancers, and glioblastomas are well-studied examples in which altered PI3K activity was observed (29–32). This evidence concerns the gene PIK3CD and B-cell chronic lymphocytic leukemia.